Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950116-05-002688
Filing Date
2005-08-09
Accepted
2005-08-09 13:47:39
Documents
16
Period of Report
2005-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q ten-q.htm 10-Q 484305
2 GRAPHIC emptybox.gif GRAPHIC 861
3 GRAPHIC tickedbox.gif GRAPHIC 897
4 EXHIBIT 10.1 ex10-1.htm EX-10 32443
5 EXHIBIT 10.2 ex10-2.htm EX-10 30891
6 EXHIBIT 10.3 ex10-3.htm EX-10 8543
7 GRAPHIC image001.jpg GRAPHIC 7118
8 EXHIBIT 10.4 ex10-4.htm EX-10 8518
9 EXHIBIT 10.5 ex10-5.htm EX-10 8425
10 EXHIBIT 10.6 ex10-6.htm EX-10 8438
11 EXHIBIT 10.7 ex10-7.htm EX-10 8581
12 EXHIBIT 10.8 ex10-8.htm EX-10 8590
13 EXHIBIT 10.9 ex10-9.htm EX-10 8546
14 EXHIBIT 31.1 ex31-1.htm EX-31 11480
15 EXHIBIT 31.2 ex31-2.htm EX-32 11506
16 EXHIBIT 32.1 ex32-1.htm EX-32 5233
  Complete submission text file 0000950116-05-002688.txt   649533
Mailing Address 41 UNIVERSITY DRIVE NEWTON PA 18940
Business Address 41 UNIVERSITY DRIVE NEWTON PA 18940 2155797388
COLLAGENEX PHARMACEUTICALS INC (Filer) CIK: 0001012270 (see all company filings)

EIN.: 521758016 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-28308 | Film No.: 051008794
SIC: 2834 Pharmaceutical Preparations